Jiangsu Hengrui Medicine Co.
Su Zhang currently serves as the CEO and Acting CBO at CoDevCo, an advisory firm specializing in cross-border business development transactions in life sciences between China and global markets. With experience spanning multiple leadership roles, Su previously held the position of VP, Global Head of Business Development at Jiangsu Hengrui Pharmaceuticals, where significant deals were negotiated totaling over $1.5 billion. Prior experience includes senior roles at Triastek, Inc., and AnLong Bio, focusing on strategy and business development in innovative pharmaceutical sectors. Su Zhang is also a former VC Fellow at Chestnut Street Ventures, and possesses advanced degrees in business administration from The Wharton School and pharmacy from the University of Iowa.
This person is not in any teams
This person is not in any offices
Jiangsu Hengrui Medicine Co.
1 followers
JIANSU HENGRUI MEDICINE CO., LTD. is a China-based company, principally engaged in the manufacture and distribution of pharmaceutical tablets, injections and raw materials. The Company's main products portfolio consists of antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents, antibiotics, specialty infusions and others. The Company distributes its products within domestic market and to overseas markets.